|Articles|April 16, 2007
Managing malignant conjunctival lesions
Ophthalmologists can be involved in managing patients with malignant conjunctival lesions, most often-pigmented conjunctival lesions, primary acquired melanosis, conjunctival melanoma, conjunctival and corneal squamous neoplasia, and squamous cell carcinomas. Nicholas T. Iliff, MD, described how these pathologies are best approached. Dr. Iliff is Maurice Bendann, Violet Bendann, Constance Bendann and Charles E. Iliff Professor of Ophthalmology, professor of plastic surgery, and director - oculoplastic surgery, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
Midyear cataract check-in: What 2026 has brought to the OR and beyond
3
Beyond the Walls: Leading with love, loyalty, and a team first philosophy with Vance Thompson, MD
4
Durability With Aflibercept 8 mg in Retinal Vascular Diseases
5

















